@jennifer-carroll Thanks - Appreciate the reply!
S
SB
@SB
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Posts
-
Digital Housing -
Digital HousingWe're building a Digital Resource Library microsite that will provide physicians with a secure, reliable way to access PAAB approved information/tools about a specific condition.
Wondering what happens each time we add/remove/renew a piece - Do we need to re-submit the entire site for review each time? Any recommendations on how best to manage tools ongoing once the site up and running?